Research, Select, & Monitor Wednesday, February 20, 2019 12:40:18 PM ET  
Trade Ideas The Market Industries Stocks Portfolio

Ticker Lookup
Altimmune, Inc.$2.89($.08)(2.69%)

  Quote | Ranking | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

 Altimmune to Announce First Quarter 2018 Financial Results on May 16
   Tuesday, May 08, 2018 8:00:00 AM ET

GAITHERSBURG, Md., May 08, 2018 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq:ALT), a clinical-stage immunotherapeutics company, today announced that it will announce financial results for the first quarter ended March 31, 2018 before the market open and host a conference call on Wednesday, May 16.

Conference Call Details
Date:                            Wednesday, May 16
Time:                            8:30am Eastern Time
Domestic:                      888-394-8218
International:                 323-701-0225
Conference ID:               1336227

Replays, Available through May 30th:
Domestic:                       844-512-2921
International:                  412-317-6671
Replay PIN:                     1336227

About Altimmune
Altimmune is a clinical-stage immunotherapeutics company focused on the development of products to stimulate robust and durable immune responses for the prevention and treatment of disease including NasoVAX, a Phase 2 seasonal influenza vaccine candidate, and HepTcell, a Phase 1 immunotherapeutic candidate for the potential cure of chronic hepatitis B. The company also has two United States government funded, next-generation anthrax vaccine candidates that are intended to improve protection and safety while having favorable dosage and storage requirements compared to other anthrax vaccines.

Bill Enright                                                                                                           
President and CEO                                                                                        
Phone: 240-654-1450                                                                            

Ashley Robinson
LifeSci Advisors, LLC


Primary Logo

Source: Altimmune, Inc.

Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results, the logo, and News Selects are trademarks of
Copyright © 1998 - 2019 All rights reserved.